The Global Biosimulation Market was valued at around USD 2.6 billion in 2021, with a projected CAGR of 21.5% for the next ten years the market is likely to reach a valuation of USD 20.9 Billion by the end of 2032. The need for developing new drugs to compact the developing diseases will drive the demand for biosimulation.
| Report Attributes | Details |
|---|---|
| Estimated Market Value (2022E) | USD 3.1 Billion |
| Forecasted Market Value (2032F) | USD 20.9 Billion |
| Global Market Growth Rate (2022 to 2032) | 21.5% CAGR |
| United States Growth Rate (2022 to 2032) | ~21.6% CAGR |
| Key Companies Covered | Certara; Dassault Systemes; Advanced Chemistry Development; Simulation Plus Inc; Schrodinger, Inc.; Chemical Computing Group; Physiomics Plc; Rosa & Co. LLC; BioSimulation Consulting Inc.; Genedata AG; Instem Group of Companies; PPD, Inc.; Insilico Biotechnology AG; Rhenovia Pharma; LeadInvent Technologies; Nuventra Pharma; In Silico Biosciences |
Future Market Insight’s analysis reveals that most of the revenue is generated from biosimulation software. On the other hand, drug development in deployment mode will be the most lucrative with a CAGR of 22.8% during the forecast period.
The global market for Biosimulation registered a CAGR of 15.8% from 2015 to 2021. The market growth is projected to surge due to technological advancement in software for biosimulation. In 2021, the global market size of biosimulation was valued at USD 2.6 Billion and is estimated to increase to a valuation of USD 3.1 Billion in 2022.
Biosimulation is the use of computer-aided mathematical models to simulate biological processes. Biosimulation has various applications like developing new drugs and discovering new drugs. The drug discovery and development process is expensive, and the failure of a therapeutic molecule in the late stages of drug development results in a massive waste of time, money, and other resources. As a result, a predictive tool is required to aid in predicting the future results of drug development through simulation of the biological processes involved.
Biosimulation helps to simulate the effect of drugs on the body with the help of simulation. Pharmaceutical manufacturers are using biosimulation throughout the drug development process to identify the positive and negative effects of their drug can have on the people if the drug is used.
The global biosimulation market has predicted to surge ahead at a CAGR of 21.5% and record sales worth USD 20.9 Billion by the end of 2032. USA will continue to be the largest procurer of biosimulation throughout the analysis period accounting for over USD 7.5 Billion absolute dollar opportunity in the coming 10-year epoch.
Rising global healthcare spending will increase spending on developing drugs, which will drive revenue for biosimulation. Many drugs for mimic diseases are developed using biosimulation. Computers operating sickness simulations with the aid of biosimulation software can be used to conduct virtual clinical trials for new pharmaceutical treatments. Developing a new drug requires significant research and studies.
Every stage of drug development from clinical trials to the approval of the drug has a serious chance of failure. Biosimulation lowers these odds by predicting these failures in the development process. Also, it lowers the cost of pharmaceutical companies by lowering the number of clinical trials.
Biosimulation uses mathematical equations to depict a real-life process that occurs within the human body. Researchers may simulate a wide range of scenarios and examine the behavior of a human system in diverse settings since it can duplicate human biological elements and their interactions with medications when they are put into the system.
In order to obtain a better result, skilled expertise is required to perform the biosimulation software. The demand for skilled expertise is high in research laboratories and companies. In addition, this process is very complex and highly technical as they involve various laboratory documentation systems. In order to overcome this issue, researchers must receive proper training and assistance. These factors make biosimulation development time-consuming, thus limiting its adoption among researchers.
North America holds the largest market for biosimulation. The rising chronic disease among the population in the region and regulations implemented by the governments for patient safety and treatment standards is driving the demand for biosimulation in the region. In silico modeling is being used to boost the standard of patient care and safety. This is particularly true for the implementation of regulatory laws that have high standards for the safety and care of patients.
The encouraging government policies in the USA and the rising healthcare expenditure due to the dominance of chronic diseases are key factors that are rising drug development and discovery in the USA. The market for biosimulation in the USA has projected to reach a valuation of USD 8.7 Billion in 2032.
The government policies for developing quality pharmaceutical drugs and the Chinese government‘s commitment to develop and increase innovation in its healthcare system are driving the market for biosimulation in China. Chinese government’s plan to be a global leader in drug development is attracting drug development and pharmaceutical companies to China for the development of new drugs, which will further increase the demand for the biosimulation market over the years. The market for biosimulation in China is forecasted to reach a valuation of USD 1.7 Billion by 2032.
The market in the United Kingdom is projected to reach a valuation of USD 880 million by 2032. The market is expected to grow at a CAGR of 20.6% from 2022 to 2032 to gross an absolute dollar opportunity of USD 336 million.
The market for biosimulation in Japan is expected to reach USD 1.2 Billion by 2032. Growing at a CAGR of 25.1% during the forecast period, the market is likely to garner an absolute dollar opportunity of USD 1.1 Billion.
The market through the CROs segment is anticipated to grow at the fastest rate during the forecast period. The growing tendency of firms to cut total spending is expected to drive segment growth. Other factors like increased efficiency and the ability to focus on core areas for company development will also drive the use of biosimulation in CROs.
The key companies operating in the biosimulation market include Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus Inc., Schrodinger, Inc., Chemical Computing Group, Physiomics Plc, Rosa & Co. LLC, BioSimulation Consulting Inc., Genedata AG, Instem Group of Companies, PPD, Inc., Insilico Biotechnology AG, Rhenovia Pharma, LeadInvent Technologies, Nuventra Pharma, and In Silico Biosciences.
Some of the recent developments by key providers of biosimulation are as follows:
Similarly, the team at Future Market Insights has tracked recent developments related to companies offering Biosimulation, which is available in the full report.
Table 1: Global Market Value (US$ million) Forecast by Region, 2015 to 2032
Table 2: Global Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 3: Global Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 4: Global Market Value (US$ million) Forecast by End Use, 2015 to 2032
Table 5: North America Market Value (US$ million) Forecast by Country, 2015 to 2032
Table 6: North America Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 7: North America Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 8: North America Market Value (US$ million) Forecast by End Use, 2015 to 2032
Table 9: Latin America Market Value (US$ million) Forecast by Country, 2015 to 2032
Table 10: Latin America Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 11: Latin America Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 12: Latin America Market Value (US$ million) Forecast by End Use, 2015 to 2032
Table 13: Europe Market Value (US$ million) Forecast by Country, 2015 to 2032
Table 14: Europe Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 15: Europe Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 16: Europe Market Value (US$ million) Forecast by End Use, 2015 to 2032
Table 17: East Asia Market Value (US$ million) Forecast by Country, 2015 to 2032
Table 18: East Asia Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 19: East Asia Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 20: East Asia Market Value (US$ million) Forecast by End Use, 2015 to 2032
Table 21: South Asia Market Value (US$ million) Forecast by Country, 2015 to 2032
Table 22: South Asia Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 23: South Asia Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 24: South Asia Market Value (US$ million) Forecast by End Use, 2015 to 2032
Table 25: Oceania Market Value (US$ million) Forecast by Country, 2015 to 2032
Table 26: Oceania Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 27: Oceania Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 28: Oceania Market Value (US$ million) Forecast by End Use, 2015 to 2032
Table 29: MEA Market Value (US$ million) Forecast by Country, 2015 to 2032
Table 30: MEA Market Value (US$ million) Forecast by Product Type, 2015 to 2032
Table 31: MEA Market Value (US$ million) Forecast by Deployment Mode, 2015 to 2032
Table 32: MEA Market Value (US$ million) Forecast by End Use, 2015 to 2032
Figure 1: Global Market Value (US$ million) by Product Type, 2022 to 2032
Figure 2: Global Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 3: Global Market Value (US$ million) by End Use, 2022 to 2032
Figure 4: Global Market Value (US$ million) by Region, 2022 to 2032
Figure 5: Global Market Value (US$ million) Analysis by Region, 2015 to 2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 8: Global Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 11: Global Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 14: Global Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 17: Global Market Attractiveness by Product Type, 2022 to 2032
Figure 18: Global Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 19: Global Market Attractiveness by End Use, 2022 to 2032
Figure 20: Global Market Attractiveness by Region, 2022 to 2032
Figure 21: North America Market Value (US$ million) by Product Type, 2022 to 2032
Figure 22: North America Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 23: North America Market Value (US$ million) by End Use, 2022 to 2032
Figure 24: North America Market Value (US$ million) by Country, 2022 to 2032
Figure 25: North America Market Value (US$ million) Analysis by Country, 2015 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 28: North America Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 31: North America Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 34: North America Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 37: North America Market Attractiveness by Product Type, 2022 to 2032
Figure 38: North America Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 39: North America Market Attractiveness by End Use, 2022 to 2032
Figure 40: North America Market Attractiveness by Country, 2022 to 2032
Figure 41: Latin America Market Value (US$ million) by Product Type, 2022 to 2032
Figure 42: Latin America Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 43: Latin America Market Value (US$ million) by End Use, 2022 to 2032
Figure 44: Latin America Market Value (US$ million) by Country, 2022 to 2032
Figure 45: Latin America Market Value (US$ million) Analysis by Country, 2015 to 2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 48: Latin America Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 51: Latin America Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 54: Latin America Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 57: Latin America Market Attractiveness by Product Type, 2022 to 2032
Figure 58: Latin America Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 59: Latin America Market Attractiveness by End Use, 2022 to 2032
Figure 60: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 61: Europe Market Value (US$ million) by Product Type, 2022 to 2032
Figure 62: Europe Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 63: Europe Market Value (US$ million) by End Use, 2022 to 2032
Figure 64: Europe Market Value (US$ million) by Country, 2022 to 2032
Figure 65: Europe Market Value (US$ million) Analysis by Country, 2015 to 2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 68: Europe Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 71: Europe Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 74: Europe Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 77: Europe Market Attractiveness by Product Type, 2022 to 2032
Figure 78: Europe Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 79: Europe Market Attractiveness by End Use, 2022 to 2032
Figure 80: Europe Market Attractiveness by Country, 2022 to 2032
Figure 81: East Asia Market Value (US$ million) by Product Type, 2022 to 2032
Figure 82: East Asia Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 83: East Asia Market Value (US$ million) by End Use, 2022 to 2032
Figure 84: East Asia Market Value (US$ million) by Country, 2022 to 2032
Figure 85: East Asia Market Value (US$ million) Analysis by Country, 2015 to 2032
Figure 86: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 88: East Asia Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 89: East Asia Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 90: East Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 91: East Asia Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 92: East Asia Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 93: East Asia Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 94: East Asia Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 95: East Asia Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 96: East Asia Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 97: East Asia Market Attractiveness by Product Type, 2022 to 2032
Figure 98: East Asia Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 99: East Asia Market Attractiveness by End Use, 2022 to 2032
Figure 100: East Asia Market Attractiveness by Country, 2022 to 2032
Figure 101: South Asia Market Value (US$ million) by Product Type, 2022 to 2032
Figure 102: South Asia Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 103: South Asia Market Value (US$ million) by End Use, 2022 to 2032
Figure 104: South Asia Market Value (US$ million) by Country, 2022 to 2032
Figure 105: South Asia Market Value (US$ million) Analysis by Country, 2015 to 2032
Figure 106: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 107: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 108: South Asia Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 109: South Asia Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 110: South Asia Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 111: South Asia Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 112: South Asia Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 113: South Asia Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 114: South Asia Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 115: South Asia Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 116: South Asia Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 117: South Asia Market Attractiveness by Product Type, 2022 to 2032
Figure 118: South Asia Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 119: South Asia Market Attractiveness by End Use, 2022 to 2032
Figure 120: South Asia Market Attractiveness by Country, 2022 to 2032
Figure 121: Oceania Market Value (US$ million) by Product Type, 2022 to 2032
Figure 122: Oceania Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 123: Oceania Market Value (US$ million) by End Use, 2022 to 2032
Figure 124: Oceania Market Value (US$ million) by Country, 2022 to 2032
Figure 125: Oceania Market Value (US$ million) Analysis by Country, 2015 to 2032
Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 128: Oceania Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 129: Oceania Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 131: Oceania Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 132: Oceania Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 134: Oceania Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 135: Oceania Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 137: Oceania Market Attractiveness by Product Type, 2022 to 2032
Figure 138: Oceania Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 139: Oceania Market Attractiveness by End Use, 2022 to 2032
Figure 140: Oceania Market Attractiveness by Country, 2022 to 2032
Figure 141: MEA Market Value (US$ million) by Product Type, 2022 to 2032
Figure 142: MEA Market Value (US$ million) by Deployment Mode, 2022 to 2032
Figure 143: MEA Market Value (US$ million) by End Use, 2022 to 2032
Figure 144: MEA Market Value (US$ million) by Country, 2022 to 2032
Figure 145: MEA Market Value (US$ million) Analysis by Country, 2015 to 2032
Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 148: MEA Market Value (US$ million) Analysis by Product Type, 2015 to 2032
Figure 149: MEA Market Value Share (%) and BPS Analysis by Product Type, 2022 to 2032
Figure 150: MEA Market Y-o-Y Growth (%) Projections by Product Type, 2022 to 2032
Figure 151: MEA Market Value (US$ million) Analysis by Deployment Mode, 2015 to 2032
Figure 152: MEA Market Value Share (%) and BPS Analysis by Deployment Mode, 2022 to 2032
Figure 153: MEA Market Y-o-Y Growth (%) Projections by Deployment Mode, 2022 to 2032
Figure 154: MEA Market Value (US$ million) Analysis by End Use, 2015 to 2032
Figure 155: MEA Market Value Share (%) and BPS Analysis by End Use, 2022 to 2032
Figure 156: MEA Market Y-o-Y Growth (%) Projections by End Use, 2022 to 2032
Figure 157: MEA Market Attractiveness by Product Type, 2022 to 2032
Figure 158: MEA Market Attractiveness by Deployment Mode, 2022 to 2032
Figure 159: MEA Market Attractiveness by End Use, 2022 to 2032
Figure 160: MEA Market Attractiveness by Country, 2022 to 2032
The global biosimulation market was valued at USD 2.6 billion in 2021.
The biosimulation industry is set to witness a high growth rate of 21.5% over the forecasted period and be valued at USD 20.9 billion by 2032.
The Biosimulation Market expanded at a CAGR of 15.8% from 2015 through 2021.
Certara, Dassault Systemes, Advanced Chemistry Development, Simulation Plus Inc, and Schrodinger, Inc. are the key providers of biosimulation.
The USA, United Kingdom, China Japan, and South Korea are expected to drive the most sales growth of Biosimulation.
The market in the USA has forecasted to account for over 40% of the global market share in 2032.
Biosimulation Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
